Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3033

Actual shortage: 240 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

29 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2017-03-10 2018-12-18 284
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-02-06 2019-07-12 74872
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-03-13 2019-07-12 78484
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2019-08-21 2019-10-15 92022
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-11-04 95871
APO-DEFERASIROX (TYPE J) 180MG TABLET Resolved 2020-03-18 2020-03-31 108927
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2020-10-07 2021-01-26 125806
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2020-11-19 2020-11-27 128594
APO-DEFERASIROX (TYPE J) 180MG TABLET Resolved 2021-01-08 2021-01-20 131148
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2021-02-26 2021-08-23 134811
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2021-06-18 2021-07-26 141247
APO-MYCOPHENOLIC ACID 180MG TABLET (ENTERIC-COATED) Resolved 2022-08-12 2023-01-13 166604
APO-CANDESARTAN 16MG TABLET Resolved 2017-03-11 2017-06-27 639
APO-CANDESARTAN 16MG TABLET Resolved 2018-01-03 2020-02-25 34838
APO-CANDESARTAN 16MG TABLET Resolved 2020-06-24 2021-06-14 118761
APO-CANDESARTAN 16MG TABLET Resolved 2020-06-24 2020-09-21 118763
APO-CANDESARTAN 16MG TABLET Resolved 2021-05-14 2021-07-30 139406
APO-CANDESARTAN 16MG TABLET Actual shortage 2022-08-12 2022-08-12 166595
APO-VALSARTAN 160MG TABLET Resolved 2017-03-11 2019-03-08 549
APO-SOTALOL 160MG TABLET Resolved 2017-10-12 2018-01-19 25636

Showing 2041 to 2060 of 3033

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-ASA LD 81MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60252
COATED DAILY LOW DOSE ASA 81 MG 81MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-04 71083
APO-FUROSEMIDE 80MG TABLET Discontinued 2017-03-30 2018-02-05 4719
APO-SOTALOL 80MG TABLET Discontinued 2017-03-31 2018-12-07 4936
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40817
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40820
APO-ATORVASTATIN 80MG TABLET Discontinued 2018-09-07 2018-12-29 60285
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4915
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-DIPYRIDAMOLE 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-CIPROFLOX 750MG TABLET Discontinued 2018-09-07 2018-12-28 60388
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310

Showing 1 to 20 of 356